Absstract of: ES2999330A1
Method for glucose control in a flexibly structured bihormonal artificial pancreas that manages optional meal and/or exercise prompts using coordinated control actions, comprising: measuring a plasma glucose signal; calculating an incremental plasma glucose measurement (y); defining a model for the incremental plasma glucose; defining a carbohydrate intake as dependent on a patient-estimated carbohydrate content; defining an expected postprandial incremental plasma glucose {IMAGE-01} dependent on the administered insulin bolus; defining an incremental plasma glucose {IMAGE-02}, an insulin infusion {IMAGE-03}, and a carbohydrate intake {IMAGE-04} corrected; defining a virtual control action μ(s), split between regulatory μr and counter-regulatory μcr actions ; and calculating the control actions using a 2-DOF feedback controller with a prefilter of nominal value Fr (s). (Machine-translation by Google Translate, not legally binding)
Nº publicación: ES2999412T3 25/02/2025
Applicant:
ABBOTT DIABETES CARE INC
Abbott Diabetes Care Inc
Absstract of: JP2024137994A
To provide analyte sensors that are responsive to at least two analytes of interest using a single enzyme-based analyte sensor.SOLUTION: Multiple enzymes may be present in one or more active areas of an electrochemical analyte sensor for detecting one or more different analytes. In particular, the analyte sensor may comprise a sensor tail configured for insertion into a tissue and one or more working electrodes having a glucose-responsive active area and an ethanol-responsive active area to detect glucose and ethanol in vivo.SELECTED DRAWING: Figure 9A